EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The harmonized activities of HER2–HER3 heterodimer and deacetylated FOXA1 evade hormone response by regulating FOXA1 chromatin binding

Shixiong Wang, Gemma Santacana-Font, Darek Kedra, Siv Gilfillan, David Tena-Chaves, Helga Bergholtz, Olav Engebraaten, Ole Christian Lingjaerde, Javier Gutiérrez-Fernández, Jens Henrik Norum, Therese Sørlie, Sandra López-Aviles und 1 weitere

Nucleic Acids Research · 2025

DOI: 10.1093/nar/gkaf1086 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nucleic Acids Research, 2025. Verfasst von Shixiong Wang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Cell cycle regulation group, Institute of Biosciences (IBV), University of Oslo, Kristine Bonnevies hus, Blindernveien 31, 0371 Oslo, Norway. Hauptthemen laut MEDLINE: Hepatocyte Nuclear Factor 3-alpha, Chromatin, Erb-b2 Receptor Tyrosine Kinases, Breast Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Horizon 2020, Programa de generación de conocimiento del Ministerio Ciencia y Tecnologia del Gobierno de España, RESCUER.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

FOXA1 is a key transcription factor that mediates the effects of estrogen receptor (ER) and HER2 signaling in breast cancer. However, the mechanisms underlying FOXA1 regulation by HER2 and ER remain poorly understood. Here, we investigated FOXA1 regulation in cells with varying HER2 levels and its impact on endocrine therapy response. Chromatin interaction analyses revealed that high HER2 levels enhance FOXA1 binding to chromatin regions while reducing ER occupancy. Mechanistically, FOXA1 is acetylated by the histone acetyltransferase EP300 at the WD1 domain in ER-positive cells, attenuating its DNA binding at HER2-induced chromatin regions. Conversely, FOXA1 deacetylation—triggered by HER2/HER3 activation—increases its binding to ER-independent regions and promotes insensitivity to hormone therapy. In a luminal breast cancer patient-derived xenograft model, HER2/HER3 signaling increased FOXA1 chromatin binding and reduced sensitivity to ER-targeted treatment. We identify HDAC2 as a key deacetylase modulating FOXA1 acetylation and partially mediating the effects of HER2/HER3 signaling. Altogether, our findings highlight the significance of FOXA1 acetylation, regulated by the HER2/HER3–HDAC2–FOXA1 axis, in controlling FOXA1 chromatin binding and shaping breast cancer progression and therapy response. These insights may inform future therapeutic strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatocyte Nuclear Factor 3-alphaChromatinErb-b2 Receptor Tyrosine KinasesBreast NeoplasmsHumansAcetylationFemaleAnimalsMiceCell Line, TumorHistone Deacetylase 2Signal TransductionReceptors, EstrogenProtein BindingGene Expression Regulation, NeoplasticMCF-7 CellsE1A-Associated p300 ProteinReceptor, ErbB-3

Substanzen

Hepatocyte Nuclear Factor 3-alphaChromatinErb-b2 Receptor Tyrosine KinasesHistone Deacetylase 2Receptors, EstrogenE1A-Associated p300 ProteinReceptor, ErbB-3FOXA1 protein, humanERBB2 protein, humanERBB3 protein, human

Autor:innen und Institutionen

  • Cell cycle regulation group, Institute of Biosciences (IBV), University of Oslo, Kristine Bonnevies hus, Blindernveien 31, 0371 Oslo, Norway.
  • Functional Cancer Genomics group, Centro de Investigación del Cáncer and Instituto de Biología Molecular y Celular del Cáncer, Consejo Superior de Investigaciones Científicas and Universidad de Salamanca, Salamanca, 370…
  • Department of Cancer Genetics, Institute for Cancer Research, The Norwegian Radium Hospital, N-0310 Oslo, Norway.
  • Department of Oncology, Oslo University Hospital, and Department of Tumor Biology, Institute for Cancer Research, University of Oslo, N-0310 Oslo, Norway.
  • Department of Computer Science, University of Oslo, P.O. 1137 Blindern, 0318 Oslo, Norway.
  • Institute of Biosciences (IBV), University of Oslo, Kristine Bonnevies hus, Blindernveien 31, 0371 Oslo, Norway.

ORCID-Profile: Antoni Hurtado

Förderung

  • Horizon 2020
  • Programa de generación de conocimiento del Ministerio Ciencia y Tecnologia del Gobierno de España
  • RESCUER
  • Programa de generación de conocimiento del Ministerio Ciencia y Tecnologia del Gobierno de España

Zitieren

APA

Wang, S., Santacana-Font, G., Kedra, D., Gilfillan, S., Tena-Chaves, D., Bergholtz, H., Engebraaten, O., Lingjaerde, O. C., Gutiérrez-Fernández, J., Norum, J. H., Sørlie, T., López-Aviles, S., & Hurtado, A. (2025). The harmonized activities of HER2–HER3 heterodimer and deacetylated FOXA1 evade hormone response by regulating FOXA1 chromatin binding. Nucleic Acids Research. https://doi.org/10.1093/nar/gkaf1086

Vancouver

Wang S, Santacana-Font G, Kedra D, Gilfillan S, Tena-Chaves D, Bergholtz H, et al. The harmonized activities of HER2–HER3 heterodimer and deacetylated FOXA1 evade hormone response by regulating FOXA1 chromatin binding. Nucleic Acids Research. 2025. doi:10.1093/nar/gkaf1086

BibTeX
@article{Wang2025,
  author = {Wang, Shixiong and Santacana-Font, Gemma and Kedra, Darek and Gilfillan, Siv and Tena-Chaves, David and Bergholtz, Helga and Engebraaten, Olav and Lingjaerde, Ole Christian and Gutiérrez-Fernández, Javier and Norum, Jens Henrik and Sørlie, Therese and López-Aviles, Sandra and Hurtado, Antoni},
  title = {The harmonized activities of HER2–HER3 heterodimer and deacetylated FOXA1 evade hormone response by regulating FOXA1 chromatin binding},
  journal = {Nucleic Acids Research},
  year = {2025},
  doi = {10.1093/nar/gkaf1086}
}
Kostenlos starten →